Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sosei Group Corporation (JP:4565)
TSE/TYO:4565
Holding JP:4565?
Track your performance easily
4565 Stock Chart & Stats
Day’s Range¥0 - ¥0
52-Week Range¥1,100.00 - ¥1,826.00
Previous Close¥1,132
Volume370.40K
Average Volume (3M)942.56K
Market Cap
¥101.77B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.65
Next Earnings
Feb 18, 2025EPS Estimate
¥60.2Last Dividend Ex-Date
Mar 27, 2015Dividend YieldN/A
Share Statistics
EPS (TTM)-41.52
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume942,557
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥1,911.47Price Target Upside68.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Sosei Group News
PremiumCompany Announcements
Nxera Pharma Gains Milestone Payment in Sleep Disorder Collaboration
PremiumCompany Announcements
Nxera Pharma Reports Robust Revenue Growth Amid Strategic Expansion
PremiumCompany Announcements
Nxera Pharma Reports Increased Revenue but Continues to Face Losses
PremiumCompany Announcements
Nxera Pharma Reports Key Milestones and Revenue Growth
PremiumCompany Announcements
Nxera Pharma Partners with Shionogi on Insomnia Drug
PremiumCompany Announcements
Nxera Pharma Secures $35M After Trial Success
PremiumCompany Announcements
Nxera Pharma Advances Schizophrenia TreatmentOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
5.27% Mutual Funds
― Other Institutional Investors
91.52% Public Companies and
Individual Investors
4565 FAQ
What was Sosei Group Corporation’s price range in the past 12 months?
Sosei Group Corporation lowest stock price was ¥1100.00 and its highest was ¥1826.00 in the past 12 months.
What is Sosei Group Corporation’s market cap?
Currently, no data Available
When is Sosei Group Corporation’s upcoming earnings report date?
Sosei Group Corporation’s upcoming earnings report date is Feb 18, 2025 which is in 85 days.
How were Sosei Group Corporation’s earnings last quarter?
Sosei Group Corporation released its earnings results on Nov 01, 2024. The company reported ¥13.45 earnings per share for the quarter, beating the consensus estimate of ¥0.282 by ¥13.168.
Is Sosei Group Corporation overvalued?
According to Wall Street analysts Sosei Group Corporation’s price is currently Undervalued.
Does Sosei Group Corporation pay dividends?
Sosei Group Corporation pays a Notavailable dividend of ¥2.5 which represents an annual dividend yield of N/A. See more information on Sosei Group Corporation dividends here
What is Sosei Group Corporation’s EPS estimate?
Sosei Group Corporation’s EPS estimate is ¥60.2.
How many shares outstanding does Sosei Group Corporation have?
Sosei Group Corporation has 89,902,855 shares outstanding.
What happened to Sosei Group Corporation’s price movement after its last earnings report?
Sosei Group Corporation reported an EPS of ¥13.45 in its last earnings report, beating expectations of ¥0.282. Following the earnings report the stock price went down -1.302%.
Which hedge fund is a major shareholder of Sosei Group Corporation?
Currently, no hedge funds are holding shares in JP:4565
---
Sosei Group Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.75%
12-Months-Change
Fundamentals
Return on Equity
-5.70%
Trailing 12-Months
Asset Growth
6.35%
Trailing 12-Months
Company Description
Sosei Group Corporation
Sosei Group Corp is an international biopharmaceutical company that develops treatments for a wide range of illnesses. The company utilizes its peptide platform technologies and nanotechnology to develop its product pipeline. Sosei actively seeks partnerships to aid its product development. The company's strategy for commercializing its therapies include utilizing its subsidiaries' drug discovery technologies, supplying technology to other companies, developing products in-house, and product licensing.
---
4565 Company Deck
---
4565 Earnings Call
Q2 2024
0:00 / 0:00
---
4565 Stock 12 Month Forecast
Average Price Target
¥1,911.47
▲(68.86% Upside)
Technical Analysis
Aditxt, Inc.
―
Arrowhead Pharmaceuticals
―
Crispr Therapeutics AG
―
Editas Medicine
―
Sosei Group
―
Best Analysts Covering 4565
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-10.10%
reiterated a buy rating last month
Copying Seiji Wakao's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -10.10% per trade.
---